First Time Loading...

Polynovo Ltd
ASX:PNV

Watchlist Manager
Polynovo Ltd Logo
Polynovo Ltd
ASX:PNV
Watchlist
Price: 2.12 AUD Market Closed
Updated: May 8, 2024

Intrinsic Value

Polynovo Ltd. engages in the provision biodegradable medical devices. [ Read More ]

The intrinsic value of one PNV stock under the Base Case scenario is 0.63 AUD. Compared to the current market price of 2.12 AUD, Polynovo Ltd is Overvalued by 70%.

Key Points:
PNV Intrinsic Value
Base Case
0.63 AUD
Overvaluation 70%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Polynovo Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling PNV stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Polynovo Ltd

Provide an overview of the primary business activities
of Polynovo Ltd.

What unique competitive advantages
does Polynovo Ltd hold over its rivals?

What risks and challenges
does Polynovo Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Polynovo Ltd.

Provide P/S
for Polynovo Ltd.

Provide P/E
for Polynovo Ltd.

Provide P/OCF
for Polynovo Ltd.

Provide P/FCFE
for Polynovo Ltd.

Provide P/B
for Polynovo Ltd.

Provide EV/S
for Polynovo Ltd.

Provide EV/GP
for Polynovo Ltd.

Provide EV/EBITDA
for Polynovo Ltd.

Provide EV/EBIT
for Polynovo Ltd.

Provide EV/OCF
for Polynovo Ltd.

Provide EV/FCFF
for Polynovo Ltd.

Provide EV/IC
for Polynovo Ltd.

Show me price targets
for Polynovo Ltd made by professional analysts.

What are the Revenue projections
for Polynovo Ltd?

How accurate were the past Revenue estimates
for Polynovo Ltd?

What are the Net Income projections
for Polynovo Ltd?

How accurate were the past Net Income estimates
for Polynovo Ltd?

What are the EPS projections
for Polynovo Ltd?

How accurate were the past EPS estimates
for Polynovo Ltd?

What are the EBIT projections
for Polynovo Ltd?

How accurate were the past EBIT estimates
for Polynovo Ltd?

Compare the revenue forecasts
for Polynovo Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Polynovo Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Polynovo Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Polynovo Ltd compared to its peers.

Compare the P/E ratios
of Polynovo Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Polynovo Ltd with its peers.

Analyze the financial leverage
of Polynovo Ltd compared to its main competitors.

Show all profitability ratios
for Polynovo Ltd.

Provide ROE
for Polynovo Ltd.

Provide ROA
for Polynovo Ltd.

Provide ROIC
for Polynovo Ltd.

Provide ROCE
for Polynovo Ltd.

Provide Gross Margin
for Polynovo Ltd.

Provide Operating Margin
for Polynovo Ltd.

Provide Net Margin
for Polynovo Ltd.

Provide FCF Margin
for Polynovo Ltd.

Show all solvency ratios
for Polynovo Ltd.

Provide D/E Ratio
for Polynovo Ltd.

Provide D/A Ratio
for Polynovo Ltd.

Provide Interest Coverage Ratio
for Polynovo Ltd.

Provide Altman Z-Score Ratio
for Polynovo Ltd.

Provide Quick Ratio
for Polynovo Ltd.

Provide Current Ratio
for Polynovo Ltd.

Provide Cash Ratio
for Polynovo Ltd.

What is the historical Revenue growth
over the last 5 years for Polynovo Ltd?

What is the historical Net Income growth
over the last 5 years for Polynovo Ltd?

What is the current Free Cash Flow
of Polynovo Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Polynovo Ltd.

Financials

Balance Sheet Decomposition
Polynovo Ltd

Current Assets 70.3m
Cash & Short-Term Investments 45.6m
Receivables 15.5m
Other Current Assets 9.2m
Non-Current Assets 26.9m
PP&E 23.6m
Intangibles 1m
Other Non-Current Assets 2.3m
Current Liabilities 14m
Accounts Payable 3.5m
Accrued Liabilities 1.9m
Other Current Liabilities 8.6m
Non-Current Liabilities 14.1m
Long-Term Debt 13.7m
Other Non-Current Liabilities 428k
Efficiency

Earnings Waterfall
Polynovo Ltd

Revenue
84.7m AUD
Cost of Revenue
-4.8m AUD
Gross Profit
79.9m AUD
Operating Expenses
-80.3m AUD
Operating Income
-425.6k AUD
Other Expenses
2m AUD
Net Income
1.6m AUD

Free Cash Flow Analysis
Polynovo Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

PNV Profitability Score
Profitability Due Diligence

Polynovo Ltd's profitability score is 37/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Years Revenue Growth
Positive Gross Profit
Exceptional Revenue Growth Forecast
ROE is Increasing
37/100
Profitability
Score

Polynovo Ltd's profitability score is 37/100. The higher the profitability score, the more profitable the company is.

PNV Solvency Score
Solvency Due Diligence

Polynovo Ltd's solvency score is 71/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Negative Net Debt
71/100
Solvency
Score

Polynovo Ltd's solvency score is 71/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

PNV Price Targets Summary
Polynovo Ltd

Wall Street analysts forecast PNV stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PNV is 2.32 AUD with a low forecast of 2.02 AUD and a high forecast of 2.89 AUD.

Lowest
Price Target
2.02 AUD
5% Downside
Average
Price Target
2.32 AUD
9% Upside
Highest
Price Target
2.89 AUD
36% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

PNV Price
Polynovo Ltd

1M 1M
-6%
6M 6M
+55%
1Y 1Y
+46%
3Y 3Y
-23%
5Y 5Y
+111%
10Y 10Y
+1 827%
Annual Price Range
2.12
52w Low
1.12
52w High
2.49
Price Metrics
Average Annual Return 41.73%
Standard Deviation of Annual Returns 75.91%
Max Drawdown -78%
Shares Statistics
Market Capitalization 1.5B AUD
Shares Outstanding 690 233 000
Percentage of Shares Shorted
N/A

PNV Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Polynovo Ltd Logo
Polynovo Ltd

Country

Australia

Industry

Health Care

Market Cap

1.5B AUD

Dividend Yield

0%

Description

Polynovo Ltd. engages in the provision biodegradable medical devices. The company is headquartered in Melbourne, Victoria and currently employs 122 full-time employees. The Company’s principal activity is the development of medical devices for various applications. The Company’s products include NovoSorb Biodegradable Temporizing Matrix (BTM) and NovoSorb technology. BTM is a man-made synthetic polymer that does not contain any biologic materials. BTM is a skin treatment. NovoSorb is a polymer, which is utilizes for the manufacture of novel medical devices, such as Biocompatible polymers. These biocompatible polymers are designed to support different functions of the body and then biodegrade into by-products that can be absorbed and excreted by the body. The company can be produced in a range of formats with different mechanical and degradation properties. In addition to NovoSorb BTM, they can be used for thermoplastic extrusions, filaments for weaving or knitting and as a solution for spray or dip coatings of other devices.

Contact

VICTORIA
Melbourne
U 2 320 Lorimer St
+61386814050.0
http://polynovo.com.au/

IPO

1998-11-26

Employees

122

Officers

CEO & Director
Mr. Swami Raote BPHARM, M.B.A.
CFO & Company Secretary
Mr. Jan-Marcel Gielen C.A.
Chief Technical & Scientific Officer
Dr. David McQuillan Ph.D.
Chief Information Officer
Mr. Philip Scorgie
Director of Operations
Mr. Ahmed Hassan
APAC Marketing & Distributor Manager
Ms. Teena Chadha
Show More
HR Manager
Ms. Monica Benyk
Principal Scientist
Dr. Tim Moore
Senior Vice President of Sales & Marketing (Americas)
Mr. Edward Graubart
Show Less

See Also

Discover More
What is the Intrinsic Value of one PNV stock?

The intrinsic value of one PNV stock under the Base Case scenario is 0.63 AUD.

Is PNV stock undervalued or overvalued?

Compared to the current market price of 2.12 AUD, Polynovo Ltd is Overvalued by 70%.